Abstract
The objective of this study was to assess the risk of toxoplasmosis in HIV-positive subjects as a basis for primary prophylaxis. A retrospective chart review of 400 consecutive patients was carried out and clinical and laboratory markers at first presentation and follow-up data on the occurrence of toxoplasmosis were recorded. Independent variables were identified, laboratory parameters were stratified, and estimates for the risk of toxoplasmosis and the impact of different variables on its occurrence were made using conventional statistical methods.
An increased risk of toxoplasmosis was strongly associated with a positive Toxoplasma gondii IgG EIA in conjunction with a CD4+ cell cont below 0.15/nl (the estimated risk of toxoplasmosis was 20% and 35% after 12 and 24 months, respectively) or a history of one or more opportunistic infections (the estimated risk was 12% and 30% after 12 and 24 months, respectively). Toxoplasma gondii-seropositive patients with CD4+ cell counts below 0.15/nl and those with antecedent opportunistic infections are most likely to develop toxoplasmosis and thus might benefit from primary prophylaxis. The risk of disease probably outweighs the risk of medication in these subjects. Prospective clinical trials are needed to define the optimal choice of drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AndersonK.P., AtlasE., AhernM.J. and WeisbrotI.M. (1983): Central nervous system toxoplasmosis in homosexual men - Am. J. Med. 75: 877–881.
CarrA., TindallB., BrewB.J., MarriottD.J., HarknessJ.L., PennyR., et al. (1992): Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS - Ann. Intern. Med. 117: 106–111.
ClotetB., SireraG., RomeuJ., GimenoJ.M., JouA., CondomM.J., et al. (1991): Twice-weekly dapsonepyrimethamine for preventing PCP and cerebral toxoplasmosis (Letter) - AIDS 5: 601–602.
GrantI.H., GoldJ. W.M., RosenblumM., NiedzwickiD. and ArmstrongD. (1990): Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS - AIDS 4: 519–521.
HofflinJ.M., ConleyF.K. and RemingtonJ.S. (1987): Model of intracerebral toxoplasmosis - J. Infect. Dis. 155: 550–557.
LevyRM, BredesenD.E. and Rosenblum, M.L. (1985): Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at the UCSF and review of the literature - J. Neurosurg. 62: 475–495.
LuftB.J. and Remington, J.S. (1992): Toxoplasmic Encephalitis in AIDS - Clin. Infect. Dis. 15: 211–222.
WankeC., TuazonC.U., KovacsA., et al. (1987): Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome: diagnosis and response to therapy - Am. J. Trop. Med. Hyg. 36: 509–516.
WongB., GoldJWM, BrownA.E., et al. (1984): Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers. Ann. Intern. Med. 100: 36–42.
ZangerleR., AllerbergerF., PohlP., FritschP. and DierichM.P. (1991): High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii - Med. Microbiol Immunol. 180: 59–66.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Stellbrink, H.J., Führer-Burow, R., Raedler, A. et al. Risk factors for severe disease due to Toxoplasma gondii in HIV-positive patients. Eur J Epidemiol 9, 633–637 (1993). https://doi.org/10.1007/BF00211438
Issue Date:
DOI: https://doi.org/10.1007/BF00211438